Arcus Biosciences Reports Fourth-Quarter and Full-Year 2022 Financial Results and Provides a Pipeline Update
Go back to Arcus Biosciences Reports Fourth-Quarter and Full-Year 2022 Financial Results and Provides a Pipeline Update| (NYSE: RCUS) | Delayed: 29.66 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $29.66 | 52 Week High | $ | |||
| Open | $29.66 | 52 Week Low | $ | |||
| Day High | $29.66 | P/E | N/A | |||
| Day Low | $29.66 | EPS | $ | |||
| Volume | 6,101 | |||||

